Miltenyi Biotec BV & Co KG

Miltenyi Biotec BV & Co KG is a company in Bergisch Gladbach, Germany that has taken part in 29 EU-funded projects since 2016, receiving €10.2M in EU funding and leading 2 as coordinator.

EU funding received€10.2M
EU projects29
As coordinator2
Running now12
First EU project2016
Latest project2026
CountryGermany
EU registration (PIC)897602402
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Miltenyi Biotec BV & Co KG's own share of each project, not the project's full budget.

  • Horizon Europe€6.2M · 14 projects
  • Horizon 2020€3.9M · 15 projects

Projects

29 EU-funded projects, newest first. Miltenyi Biotec BV & Co KG led 2 of them as coordinator. Each links to the official record.

  • iN-KEYPartner

    iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €1.1Mtheir share
  • RAMP-UPAssociated partner

    Regenerative Medicine and Advanced Medicinal Therapeutic Products United for PhD excellence

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • S.O.L.A.R.I.S.Coordinator

    A NEW DAWN IN NEXT-GENERATION CAR-T MANUFACTURING

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €2.1Mtheir share
  • LifeLUNGPartner

    Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €290ktheir share
  • spaXioAssociated partner

    Spatial Crosstalk in Immuno-Oncology

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • T-RAFICPartner

    Training network for tracking and controlling therapeutic immune cells in cancer

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €261ktheir share
  • NANO4TALENTAssociated partner

    Post-doctoral talent attraction programme to boost research career in the field of nanomaterials for biomedicine

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ERDERAAssociated partner

    EUROPEAN RARE DISEASES RESEARCH ALLIANCE

    Horizon Europe · 2024–2031 · Project on CORDIS ↗

  • ARTiDePartner

    Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • FANTOMAssociated partner

    Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • T-FITNESSPartner

    FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €754ktheir share
  • GetRadiPartner

    Gene Therapy of Rare Diseases

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €261ktheir share
  • GLIORESOLVEAssociated partner

    Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • FAIR CHARMPartner

    Fast Infrared Coherent Harmonic Microscopy

    Horizon 2020 · 2022–2026 · Project on CORDIS ↗

    €792ktheir share
  • T-OPPartner

    Training Network for Optimizing Adoptive T cell Therapy of Cancer

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €253ktheir share
  • REAPPartner

    Revealing drug tolerant persister cells in cancer using contrast enhanced optical coherence and photoacoustic tomography

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €657ktheir share
  • T2EVOLVEPartner

    Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €278ktheir share
  • INsTRuCTPartner

    INnovative Training in Myeloid Regulatory Cell Therapy

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €277ktheir share
  • HUGODECAPartner

    Human Gonad Developmental Cell Atlas

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €243ktheir share
  • NSC-ReconstructPartner

    Novel Strategies for Cell-based Neural Reconstruction

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €323ktheir share
  • ZENITHPartner

    ZEbrafish Neuroscience Interdisciplinary Training Hub

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • RESTOREPartner

    RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €6ktheir share
  • ENDONANOPartner

    Quantitative detection of bacterial endotoxin by novel nanotechnological approaches

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €288ktheir share
  • EUROoCPartner

    Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €225ktheir share
  • MATURE-NKPartner

    MAnufacturing of TUmour-REactive Natural Killer cells

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €187ktheir share
  • TRACEPartner

    Transfer of multivirus-specific T-cells following transplantation

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €130ktheir share
  • CARATCoordinator

    Chimeric Antigen Receptors (CARs) for Advanced Therapies

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €172ktheir share
  • PIX4LIFEPartner

    Silicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible Range

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €88ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biosensing
  • business and management
  • cells technologies
  • computational science
  • diabetes
  • drug discovery
  • ecosystems
  • gene therapy
  • immunology
  • immunotherapy
  • innovation management
  • laser physics
  • manufacturing engineering
  • metalloids

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime